Astral's chemicals demerger sharpens business focus, but investors remain unconvinced. The key question is whether the spin-off can revive margins and justify the stock's rich valuation.
Astral's recent chemicals demerger aims to sharpen its business focus, a move intended to unlock value for investors. However, market sentiment remains unconvinced, questioning whether the spin-off can significantly improve margins and justify the stock's current high valuation.…
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.